The Role of Allopurinol in Digital Replantation
- 1 June 1999
- journal article
- clinical trial
- Published by SAGE Publications in Journal of Hand Surgery (European Volume)
- Vol. 24 (3) , 325-327
- https://doi.org/10.1054/jhsb.1998.0215
Abstract
The clinical effects of allopurinol on the attenuation of reperfusion injury in thumb replantations after prolonged ischaemic time were studied in a randomized control trial with a 2-year follow-up. There were 60 patients, in the trial group, and 38 patients in the control group. All were young, healthy labourers who had sharp or locally crushed amputations of the thumb at the proximal phalanx with a total ischaemic time of more than 10 hours. The standard management for thumb replantation was used in these patients, except that 300 mg allopurinol was given orally in the trial group on admission and a further 300 mg for another 5 days. After operation, the trial group had a lower infection rate, and less postoperative pain and chronic swelling than the control group. Recovery of sensation was also better in the trial group.Keywords
This publication has 6 references indexed in Scilit:
- One hundred sixty-seven thumb replantations and revascularisations: Early microvascular resultsMicrosurgery, 1996
- Protection of the Ischemic Skeletal MuscleThe Thoracic and Cardiovascular Surgeon, 1991
- Principles of Evaluation and Results in Microsurgical Treatment of Major Limb Amputations: A Follow-up Study of 26 Consecutive Cases 1978–1987Scandinavian Journal of Plastic and Reconstructive Surgery and Hand Surgery, 1990
- Present Indications and Contraindications for Replantation as Reflected by Long-Term Functional ResultsOrthopedic Clinics of North America, 1981
- Superoxide radicals in feline intestinal ischemiaGastroenterology, 1981